Overview

The Therapeutic Value and Mechanism of Recombinant Human Interleukin-2 in Children With Henoch-schönlein Purpura

Status:
Recruiting
Trial end date:
2022-12-31
Target enrollment:
Participant gender:
Summary
The study aims to explore the therapeutic value and mechanism of Interleukin-2 on children with Henoch-schönlein purpura.
Phase:
N/A
Details
Lead Sponsor:
First Hospital of Jilin University
The First Hospital of Jilin University
Treatments:
Aldesleukin
Interleukin-2